Interpretation of 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes
-
摘要: 《2024 ESC慢性冠状动脉综合征管理指南》对慢性冠状动脉综合征(CCS)进行了重新定义，并基于最新研究结果提出了多项建议与更新，涵盖从风险评估、诊断到治疗的各个环节。新指南的发布不仅为临床医生提供了最新的科学建议，也代表了CCS诊断治疗理念的持续进步，为CCS患者的高质量管理提供了重要依据。Abstract: In August 2024, the European Society of Cardiology(ESC) published the 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. The new guidelines redefine chronic coronary syndrome(CCS) and provide recommendations and updates based on the latest research findings, covering all aspects of risk assessment, diagnosis and treatment. The release of the new guidelines not only provides clinicians with the latest scientific advice, but also represents the continuous progress of the concept of diagnosis and treatment of CCS, and provides an important basis for the high-quality management of CCS patients.
-
Key words:
- chronic coronary syndrome /
- diagnosis /
- treatment /
- management /
- guidelines
-
-
图 1 阻塞性CAD临床可能性的评估及校正流程图
Figure 1. Flow chart for evaluating and correcting the clinical diagnosis of obstructive CAD
表 1 疑似CCS患者的评估策略
Table 1. Evaluation strategies for suspected CCS patients
阻塞性CAD的RF-CL模型 对疑似CCS患者的一线检测手段 非常高(>85%) 有创冠状动脉造影 高(50%~85%) 功能影像(PET/SPECT、CMR、负荷超声心动图) 中(15%~50%) CCTA或功能影像(PET/SPECT、CMR、负荷超声心动图) 低(5%~15%) 校正临床风险或CCTA 非常低(≤5%) 延迟进一步检查 
下载: 导出CSV
-
[1] Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes[J]. Eur Heart J, 2024 Aug 30: ehae177. doi: 10.1093/eurheartj/ehae177.
[2] Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477.
[3] Winther S, Schmidt SE, Mayrhofer T, et al. Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease[J]. J Am Coll Cardiol, 2020, 76(21): 2421-2432. doi: 10.1016/j.jacc.2020.09.585
[4] Koo BK, Kang J, Park KW, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention(HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial[J]. Lancet, 2021, 397(10293): 2487-2496. doi: 10.1016/S0140-6736(21)01063-1
[5] Kang J, Park KW, Lee H, et al. Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: The HOST-EXAM Extended Study[J]. Circulation, 2023, 147(2): 108-117. doi: 10.1161/CIRCULATIONAHA.122.062770
-
图(1)
表(1)
计量
- 文章访问数: 1380
- PDF下载数: 1039
- 施引文献: 0